Protect Yourself While There’s Still Time …

The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.

4 simple steps to protect your privacy and money before it’s too late.

ABCL Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 32.45%

Insider Buying (Last 12 Months): $1,096,885.00

Insider Selling (Last 12 Months): $0.00

AbCellera Biologics Insider Trading History Chart

AbCellera Biologics Share Price & Price History

^$3.76

▲ +0.13 (3.58%)

As of 04/26/2024 01:00 AM ET

Days: 30 | 90 | 365

Move Your Money Before May 1

From Stansberry Research | Ad

Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens?

Click here to get the full story before May 1.

AbCellera Biologics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/26/2023	Andrew Booth	CFO	Buy	14,500	$6.85	$99,325.00	153,000
5/26/2023	Holdings Ltd. Thermopylae	Major Shareholder	Buy	153,000	$6.52	$997,560.00	56,012,493
12/16/2022	Holdings Ltd. Thermopylae	Major Shareholder	Buy	85,102	$10.10	$859,530.20	55,859,493
8/19/2022	Holdings Ltd. Thermopylae	Major Shareholder	Buy	200,000	$11.46	$2,292,000.00	55,844,391
6/13/2022	Holdings Ltd. Thermopylae	Major Shareholder	Buy	54,915	$8.03	$440,967.45	55,635,218
6/6/2022	Holdings Ltd. Thermopylae	Major Shareholder	Buy	64,545	$7.50	$484,087.50	55,580,303
5/16/2022	Veronique Lecault	COO	Buy	200,000	$6.34	$1,268,000.00	1,770,122
5/12/2022	Andrew Booth	CFO	Buy	85,000	$5.79	$492,150.00	138,500
5/12/2022	Holdings Ltd. Thermopylae	Major Shareholder	Buy	1,408,468	$6.41	$9,028,279.88	55,215,758
3/4/2022	John S. Montalbano	Director	Buy	10,000	$8.54	$85,400.00
3/1/2022	John S. Montalbano	Director	Buy	20,000	$9.05	$181,000.00
2/28/2022	Veronique Lecault	COO	Buy	230,789	$8.66	$1,998,632.74
12/3/2021	Andrew Lo	Director	Buy	86,938	$14.02	$1,218,870.76
11/11/2021	Andrew Booth	CFO	Buy	53,500	$14.74	$788,590.00
11/11/2021	Holdings Ltd. Thermopylae	Major Shareholder	Buy	202,960	$14.76	$2,995,689.60
8/31/2021	John Hamer	Director	Sell	162,649	$16.95	$2,756,900.55
8/16/2021	John S. Montalbano	Director	Buy	6,000	$17.23	$103,380.00
6/22/2021	Michael R. Hayden	Director	Sell	100,000	$25.50	$2,550,000.00
6/9/2021	Andrew Booth	CFO	Sell	1,200,000	$25.50	$30,600,000.00
6/9/2021	Carl L. G. Hansen	CEO	Sell	6,000,000	$24.13	$144,780,000.00
6/9/2021	Holdings Ltd. Thermopylae	Major Shareholder	Sell	5,598,420	$24.03	$134,530,032.60	55,604,330
6/9/2021	Veronique Lecault	COO	Sell	1,000,000	$25.50	$25,500,000.00	1,006,000

Move Your Money Before May 1

From Stansberry Research | Ad

Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens?

Click here to get the full story before May 1.

SEC Filings (Institutional Ownership Changes) for AbCellera Biologics (NASDAQ:ABCL)

61.42% of AbCellera Biologics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

AbCellera Biologics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/22/2024	PFG Investments LLC	16,600	$75K	0.0%	N/A	0.006%
4/15/2024	TrueMark Investments LLC	109,957	$0.50M	0.5%	+13.5%	0.038%
4/12/2024	Pacifica Partners Inc.	8,619	$39K	0.0%	+78.8%	0.003%
3/15/2024	B. Riley Wealth Advisors Inc.	19,500	$0.11M	0.0%	+85.7%	0.007%
2/13/2024	Tower Research Capital LLC TRC	6,285	$36K	0.0%	-25.8%	0.002%
2/13/2024	Capital World Investors	8,351,293	$47.69M	0.0%	-0.8%	2.878%
2/9/2024	Aigen Investment Management LP	15,724	$90K	0.0%	-81.9%	0.005%
2/8/2024	Vanguard Personalized Indexing Management LLC	14,259	$81K	0.0%	N/A	0.005%
2/8/2024	Mitsubishi UFJ Asset Management Co. Ltd.	38,855	$0.22M	0.0%	+13.6%	0.013%
2/7/2024	Principal Financial Group Inc.	111,188	$0.64M	0.0%	+19.6%	0.038%
2/7/2024	Jump Financial LLC	247,597	$1.41M	0.0%	-9.8%	0.085%
2/5/2024	Intellectus Partners LLC	887,283	$5.07M	1.5%	+1.2%	0.306%
2/1/2024	Duality Advisers LP	111,041	$0.63M	0.1%	-31.5%	0.038%
2/1/2024	Handelsbanken Fonder AB	45,400	$0.26M	0.0%	+13.5%	0.016%
2/1/2024	Signaturefd LLC	10,596	$61K	0.0%	+306.3%	0.004%
1/31/2024	Federated Hermes Inc.	3,117,680	$17.80M	0.0%	-4.2%	1.074%
1/26/2024	Baillie Gifford & Co.	24,044,796	$137.30M	0.1%	-8.2%	8.286%
1/24/2024	Stratos Wealth Advisors LLC	43,500	$0.25M	0.0%	-10.3%	0.015%
1/24/2024	China Universal Asset Management Co. Ltd.	33,566	$0.19M	0.0%	+352.2%	0.012%
1/19/2024	JGP Global Gestao de Recursos Ltda.	17,417	$99K	0.1%	N/A	0.006%
1/16/2024	Raymond James Financial Services Advisors Inc.	10,935	$62K	0.0%	N/A	0.004%
1/16/2024	Raymond James & Associates	12,386	$71K	0.0%	-23.2%	0.004%
1/12/2024	Cedar Brook Financial Partners LLC	39,668	$0.22M	0.0%	+31.1%	0.014%
1/11/2024	TrueMark Investments LLC	96,853	$0.55M	0.6%	N/A	0.033%
1/8/2024	Pacifica Partners Inc.	4,820	$28K	0.0%	+82.9%	0.002%
1/5/2024	Green Alpha Advisors LLC	27,827	$0.16M	0.1%	-29.3%	0.010%
12/1/2023	B. Riley Wealth Advisors Inc.	10,500	$48K	0.0%	N/A	0.004%
11/30/2023	American Century Companies Inc.	954,623	$4.39M	0.0%	-14.2%	0.329%
11/22/2023	Graham Capital Management L.P.	180,389	$0.83M	0.0%	+149.4%	0.062%
11/15/2023	GSA Capital Partners LLP	146,190	$0.67M	0.1%	+1,268.1%	0.050%
11/15/2023	AXQ Capital LP	27,000	$0.12M	0.0%	N/A	0.009%
11/15/2023	Stansberry Asset Management LLC	112,467	$0.52M	0.1%	+9.5%	0.039%
11/14/2023	Lazard Asset Management LLC	3,146,833	$14.48M	0.0%	-3.9%	1.084%
11/14/2023	Schonfeld Strategic Advisors LLC	358,400	$1.65M	0.0%	+143.1%	0.124%
11/14/2023	Trexquant Investment LP	272,158	$1.25M	0.0%	+458.5%	0.094%
11/13/2023	Algert Global LLC	30,100	$0.14M	0.0%	N/A	0.010%
11/13/2023	Federated Hermes Inc.	3,254,353	$14.97M	0.0%	-3.5%	1.122%
11/13/2023	Dark Forest Capital Management LP	278,618	$1.28M	0.1%	+199.6%	0.096%
11/13/2023	Aigen Investment Management LP	86,795	$0.40M	0.1%	N/A	0.030%
11/13/2023	Baillie Gifford & Co.	26,204,649	$120.54M	0.1%	-0.6%	9.031%
11/9/2023	Skandinaviska Enskilda Banken AB publ	83,867	$0.39M	0.0%	+3.7%	0.029%
11/8/2023	Pathstone Family Office LLC	17,390	$80K	0.0%	+16.5%	0.006%
11/8/2023	Janney Montgomery Scott LLC	19,064	$88K	0.0%	N/A	0.007%
11/7/2023	Barclays PLC	20,986	$97K	0.0%	-96.0%	0.007%
11/7/2023	Cookson Peirce & Co. Inc.	20,000	$92K	0.0%	N/A	0.007%
11/7/2023	Jump Financial LLC	274,502	$1.26M	0.0%	-28.1%	0.095%
11/4/2023	NBC Securities Inc.	6,720	$30K	0.0%	N/A	0.002%
11/2/2023	Principal Financial Group Inc.	92,971	$0.43M	0.0%	+28.2%	0.032%
11/2/2023	Duality Advisers LP	162,200	$0.75M	0.1%	+30.4%	0.056%
10/31/2023	China Universal Asset Management Co. Ltd.	7,423	$34K	0.0%	+96.1%	0.003%
10/30/2023	Sumitomo Mitsui Trust Holdings Inc.	62,759	$0.29M	0.0%	+33.8%	0.022%
10/24/2023	Stratos Wealth Advisors LLC	48,500	$0.22M	0.0%	N/A	0.017%
10/24/2023	Raymond James & Associates	16,132	$74K	0.0%	-69.5%	0.006%
10/17/2023	Cedar Brook Financial Partners LLC	30,250	$0.14M	0.0%	+19.8%	0.010%
10/11/2023	Vontobel Holding Ltd.	10,003	$46K	0.0%	N/A	0.003%
10/10/2023	Green Alpha Advisors LLC	39,364	$0.18M	0.1%	-27.7%	0.014%
10/10/2023	National Bank of Canada FI	6,085	$27K	0.0%	+392.7%	0.002%
9/21/2023	Barclays PLC	525,964	$3.40M	0.0%	+1.0%	0.182%
8/23/2023	CTC Alternative Strategies Ltd.	18,100	$0.12M	0.1%	N/A	0.006%
8/14/2023	Ergoteles LLC	418,902	$2.71M	0.1%	+1,095.2%	0.145%
8/14/2023	ArrowMark Colorado Holdings LLC	4,105,095	$26.52M	0.3%	N/A	1.419%
8/14/2023	Prosight Management LP	2,550,000	$16.47M	5.1%	+238.4%	0.881%
8/14/2023	Graham Capital Management L.P.	72,329	$0.47M	0.0%	-84.7%	0.025%
8/11/2023	Renaissance Technologies LLC	2,536,603	$16.39M	0.0%	-9.8%	0.877%
8/11/2023	Credit Suisse AG	4,574,586	$29.55M	0.0%	-0.7%	1.581%
8/11/2023	Trexquant Investment LP	48,728	$0.32M	0.0%	N/A	0.017%
8/11/2023	Capital World Investors	8,420,493	$54.40M	0.0%	-9.7%	2.910%
8/11/2023	ExodusPoint Capital Management LP	214,557	$1.39M	0.0%	-14.9%	0.074%
8/10/2023	Cetera Advisors LLC	16,277	$0.11M	0.0%	+49.9%	0.006%
8/9/2023	Mitsubishi UFJ Kokusai Asset Management Co. Ltd.	34,214	$0.22M	0.0%	+126.1%	0.012%
8/7/2023	Principal Financial Group Inc.	72,521	$0.47M	0.0%	+50.9%	0.025%
8/7/2023	Mirabella Financial Services LLP	93,912	$0.61M	0.1%	N/A	0.033%
8/3/2023	Barclays PLC	525,964	$3.40M	0.0%	+1.0%	0.182%
8/3/2023	Gruss & Co. LLC	100,000	$0.65M	3.9%	-40.3%	0.035%
8/2/2023	Bank of Montreal Can	64,442	$0.49M	0.0%	N/A	0.022%
8/2/2023	Handelsbanken Fonder AB	40,000	$0.26M	0.0%	N/A	0.014%
8/1/2023	Truist Financial Corp	53,638	$0.35M	0.0%	-22.9%	0.019%
7/31/2023	Duality Advisers LP	124,375	$0.80M	0.1%	-1.6%	0.043%
7/31/2023	Intellectus Partners LLC	877,433	$5.67M	1.7%	+0.6%	0.304%
7/28/2023	Baillie Gifford & Co.	26,364,751	$170.32M	0.1%	+33.0%	9.131%
7/27/2023	Victory Capital Management Inc.	26,314	$0.17M	0.0%	-84.9%	0.009%
7/27/2023	Virtu Financial LLC	30,276	$0.20M	0.0%	N/A	0.010%
7/25/2023	Raymond James & Associates	52,824	$0.34M	0.0%	+12.1%	0.018%
7/21/2023	Creative Planning	11,703	$76K	0.0%	N/A	0.004%
7/20/2023	Cannon Global Investment Management LLC	30,000	$0.19M	1.0%	N/A	0.010%
7/18/2023	Rothschild Investment Corp IL	23,500	$0.15M	0.0%	-22.4%	0.008%
7/13/2023	Cambridge Investment Research Advisors Inc.	34,743	$0.22M	0.0%	-4.6%	0.012%
7/6/2023	Green Alpha Advisors LLC	54,415	$0.35M	0.2%	+14.0%	0.019%
6/27/2023	Duality Advisers LP	126,388	$0.95M	0.1%	N/A	0.044%
5/12/2023	Prosight Management LP	753,528	$5.68M	2.7%	+133.5%	0.261%
5/12/2023	HRT Financial LP	556,274	$4.19M	0.1%	N/A	0.193%
5/12/2023	Martingale Asset Management L P	182,107	$1.37M	0.0%	+49.4%	0.063%
5/12/2023	Dark Forest Capital Management LP	15,190	$0.12M	0.0%	+904.0%	0.005%
5/12/2023	Pearl River Capital LLC	32,458	$0.25M	0.1%	+67.6%	0.011%
5/12/2023	Gruss & Co. LLC	167,500	$1.26M	8.0%	-34.4%	0.058%
5/11/2023	Toronto Dominion Bank	60,026	$0.45M	0.0%	+1,341.5%	0.021%
5/11/2023	ExodusPoint Capital Management LP	252,192	$1.90M	0.0%	+39.8%	0.087%
5/11/2023	American Century Companies Inc.	1,292,592	$9.59M	0.0%	+0.3%	0.448%
5/10/2023	Credit Suisse AG	4,608,160	$34.75M	0.0%	+12.4%	1.596%
5/10/2023	Capula Management Ltd	59,560	$0.45M	0.0%	N/A	0.021%

Data available starting January 2016

AbCellera Biologics Inc. builds an engine for antibody drug discovery and development. Its engine discovers antibodies from natural immune responses, which are pre-enriched for antibodies. The company's preclinical products are ABCL635 for metabolic and endocrine conditions; and ABCL575 for atopic dermatitis. It has a research collaboration and license agreement with Eli Lilly and Company; and a research collaboration with Confo Therapeutics for the discovery of therapeutic antibody candidates targeting two undisclosed GPCR targets, as well as strategic collaboration with Biogen Inc. to discover therapeutic antibodies for neurological conditions. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.

Today's Range

Now: $3.76

$3.64

$3.80

50 Day Range

MA: $4.59

$3.63

$5.34

52 Week Range

Now: $3.76

$3.62

$8.05

Volume

1,365,511 shs

Average Volume

1,372,862 shs

Market Capitalization

$1.10 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.36

Who are the company insiders with the largest holdings of AbCellera Biologics?: AbCellera Biologics' top insider shareholders include:
Holdings Ltd Thermopylae (Major Shareholder)
Veronique Lecault (COO)
Andrew Booth (CFO)
Learn More about top insider investors at AbCellera Biologics.
Who are the major institutional investors of AbCellera Biologics?: AbCellera Biologics' top institutional shareholders include:
TrueMark Investments LLC — 0.04%
PFG Investments LLC — 0.01%
Pacifica Partners Inc. — 0.00%
Learn More about top institutional investors of AbCellera Biologics stock.
Which major investors are buying AbCellera Biologics stock?: Within the previous quarter, ABCL stock was purchased by institutional investors including:
PFG Investments LLC
TrueMark Investments LLC
Pacifica Partners Inc.
Within the previous year, these company insiders have bought AbCellera Biologics stock:
Holdings Ltd Thermopylae (Major Shareholder)
Veronique Lecault (COO)
Andrew Booth (CFO)
Learn More investors buying AbCellera Biologics stock.